April 20, 2018 - By Maria Robertson

CSPC PHARMACEUTICAL GROUP LTD. ORDINARY (OTCMKTS:CHJTF) showed a decrease of 32.82% in short interest. In April was published CHJTF’s total 176,000 short interest by FINRA. Previously was reported down change of 32.82% from 262,000 shares. Former CHJTF’s position will need 4 days to restore. It has 40,200 average volume.

At traded at $2.84 lastly.It’s since April 20, 2017 and is 0.00% down. The stock underperformed the S&P 500 by 11.55%.

CSPC Pharmaceutical Group Limited, an investment holding company, makes and sells pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally.The firm is worth $16.51 billion. It operates through Finished Drugs, Antibiotics, Vitamin C, and Caffeine and Others divisions.48.97 is the P/E ratio. The firm offers finished drugs, such as NBP series used for acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning series to treat hypertension and angina pectoris; Duomeisu, a chemotherapy drug for lymphoma, multiple myeloma, and ovarian and breast cancer; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; Ailineng for nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion; and Nuolining, a small molecule targeted cancer drug.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.